Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dejan Milentijevic PhD, MBA"'
Autor:
W. Frank Peacock MD, FACEP, FACC, FESC, James M. Crawford MD, PhD, Yen-Wen (Cindy) Chen PhD, Veronica Ashton MPH, Alicia K. Campbell PharmD, Dejan Milentijevic PhD, MBA, Alex C. Spyropoulos MD, FACP, FCCP, FRCPC
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Limited data are available on thromboembolic events (TEEs) and mortality in outpatients with coronavirus disease 2019 (COVID-19). This retrospective, observational cohort study identified non-hospitalized COVID-19 outpatients (01/21/2020-01/07/2021)
Externí odkaz:
https://doaj.org/article/e763408b7d534e61adeac7384af2b8bb
Autor:
Olivia S. Costa PharmD, Jan Beyer-Westendorf MD, Veronica Ashton MPH, Dejan Milentijevic PhD, MBA, Kenneth Todd Moore MS, Thomas J. Bunz PharmD, PhD, Craig I. Coleman PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
African Americans (AAs) and obese individuals have increased thrombotic risk. This study evaluated the effectiveness and safety of rivaroxaban versus warfarin in obese, AAs with nonvalvular atrial fibrillation (NVAF) or venous thromboembolism (VTE).
Externí odkaz:
https://doaj.org/article/1dacf04f817f4ecbae22ce1b2050b4fa